3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Glioblastoma
154
Brain Neoplasms
73
Glioma
69
Central Nervous System Neoplasms
50
Gliosarcoma
46
Astrocytoma
37
Melanoma
36
Oligodendroglioma
29
Neuroblastoma
17
Neoplasm Metastasis
14
Carcinoma, Non-Small-Cell Lung
12
Lung Neoplasms
11
Sarcoma, Ewing
10
Sarcoma
10
Neoplasms
10
Medulloblastoma
10
Recurrence
9
Neuroendocrine Tumors
9
Lymphoma
8
Ependymoma
8
Breast Neoplasms
8
Small Cell Lung Carcinoma
7
Rhabdomyosarcoma
7
Diffuse Intrinsic Pontine Glioma
7
Colorectal Neoplasms
7
Carcinoma, Neuroendocrine
6
Adenoma, Islet Cell
6
Uveal Melanoma
5
Spinal Cord Neoplasms
5
Pheochromocytoma
5
Interventions
venetoclax
1
tafasitamab
1
fludarabine
1
acalabrutinib
1
Valganciclovir
1
Temozolomide
1
Standard of Care
1
Radiotherapy
1
Lenalidomide
1
Drug Therapy
1
Cytarabine
1
Cyclophosphamide
1
Blood Specimen Collection
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Pyloric Stenosis, Hypertrophic
×
Temozolomide
×
Clear all
NCT06861244
2026-04-23
PNOC031
University of California, San Francisco
Phase 2
Recruiting
70 enrolled